We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.62B
AUM Growth
-$62.4M
Cap. Flow
-$203M
Cap. Flow %
-12.53%
Top 10 Hldgs %
11.78%
Holding
792
New
346
Increased
157
Reduced
185
Closed
89

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$46.2M
2
ABBV icon
AbbVie
ABBV
+$29.9M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.4M
4
EBAY icon
eBay
EBAY
+$20.5M
5
TEAM icon
Atlassian
TEAM
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 18.44%
3 Consumer Discretionary 15.45%
4 Industrials 9.36%
5 Financials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVTC icon
201
Evertec
EVTC
$1.83B
$1.79M 0.11%
52,510
+4,610
+10% +$146K
FLXN
202
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.77M 0.11%
85,474
+66
+0.1% +$1.11K
MCK icon
203
McKesson
MCK
$98.5B
$1.77M 0.11%
+12,775
New +$1.81M
MSTR icon
204
Strategy Inc
MSTR
$33.5B
$1.76M 0.11%
123,160
-1,840
-1% -$27.4K
CDNA icon
205
CareDx
CDNA
$1.92B
$1.76M 0.11%
81,403
+45,999
+130% +$1.06M
HALO icon
206
Halozyme
HALO
$9.72B
$1.74M 0.11%
97,934
+9,534
+11% +$165K
RDUS
207
DELISTED
Radius Health, Inc.
RDUS
$1.7M 0.1%
84,100
+9,262
+12% +$225K
ATRA icon
208
Atara Biotherapeutics
ATRA
$71.2M
$1.68M 0.1%
4,073
+2,773
+213% +$956K
FCF icon
209
First Commonwealth Financial
FCF
$2.12B
$1.68M 0.1%
115,590
-12,081
-9% -$170K
VRTU
210
DELISTED
Virtusa Corporation
VRTU
$1.65M 0.1%
36,497
-214
-0.6% -$8.73K
TCMD icon
211
Tactile Systems Technology
TCMD
$620M
$1.63M 0.1%
24,100
+6,000
+33% +$332K
GMS
212
DELISTED
GMS Inc
GMS
$1.62M 0.1%
59,670
+4,876
+9% +$143K
ADVM
213
DELISTED
Adverum Biotechnologies
ADVM
$1.59M 0.1%
+13,820
New +$1.22M
PRGS icon
214
Progress Software
PRGS
$1.55B
$1.58M 0.1%
38,036
-6,164
-14% -$250K
WMS icon
215
Advanced Drainage Systems
WMS
$10.9B
$1.58M 0.1%
40,656
+3,036
+8% +$112K
MTSI icon
216
MACOM Technology Solutions
MTSI
$20.4B
$1.57M 0.1%
59,122
-51,114
-46% -$1.22M
PATK icon
217
Patrick Industries
PATK
$2.8B
$1.55M 0.1%
44,366
+1,457
+3% +$47.3K
ANAB icon
218
AnaptysBio
ANAB
$1.6B
$1.54M 0.1%
+94,971
New +$2.25M
IBP icon
219
Installed Building Products
IBP
$6.13B
$1.53M 0.09%
22,200
-4
-0% -$270
GRPN icon
220
Groupon
GRPN
$980M
$1.53M 0.09%
31,947
LNW
221
DELISTED
Light & Wonder
LNW
$1.52M 0.09%
+56,676
New +$1.46M
PRMW
222
DELISTED
Primo Water Corporation
PRMW
$1.51M 0.09%
110,552
-28,048
-20% -$366K
CPRX
223
DELISTED
Catalyst Pharmaceutical
CPRX
$1.48M 0.09%
395,782
+210,977
+114% +$987K
SGMO
224
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.48M 0.09%
176,203
-54,425
-24% -$500K
BMCH
225
DELISTED
BMC Stock Holdings, Inc
BMCH
$1.47M 0.09%
51,306
-5,772
-10% -$162K

Similar funds

PDT Partners's Q4 2019 Portfolio in Review

As of Q4 2019, PDT Partners held 792 positions worth $1.62B, down 3.7% from $1.68B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

PDT Partners withdrew a net $203M in Q4 2019, closing 89 positions and reducing 185 holdings. Its most notable exit was Linde, an estimated $46.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Micron Technology worth $10.6M.

  • PDT Partners's largest Q4 2019 buy was Micron Technology: 197,601 shares worth $10.6M.
  • PDT Partners added most to Bausch Health in Q4 2019, an estimated $5.3M increase.
  • PDT Partners's biggest Q4 2019 reduction was AbbVie, cutting an estimated $29.9M.
  • PDT Partners fully exited Linde in Q4 2019, selling an estimated $46.2M.
  • PDT Partners's ten largest holdings make up 12% of its $1.62B portfolio in Q4 2019.
  • PDT Partners opened 346 new positions and closed 89 in Q4 2019.
  • PDT Partners's portfolio value fell 3.7% quarter-over-quarter to $1.62B.

Based on PDT Partners's 13F filing for Q4 2019, filed 14 Feb 2020.